impact factor, citescore
logo
 

Letters to the Editor

 

Rituximab in ankylosing spondylitis: a promising option when other treatments are not viable


1, 2

 

  1. Department of Rheumatology, Tekirdag Namik Kemal University, Tekirdag, Turkey. dilarabulutgokten@gmail.com
  2. Department of Rheumatology, Tekirdag Namik Kemal University, Tekirdag, Turkey.

CER18231
2025 Vol.43, N°3
PI 0548, PF 0549
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 39625821 [PubMed]

Received: 13/10/2024
Accepted : 13/11/2024
In Press: 29/11/2024
Published: 12/03/2025

Rheumatology Article